Партнерка на США и Канаду по недвижимости, выплаты в крипто
- 30% recurring commission
- Выплаты в USDT
- Вывод каждую неделю
- Комиссия до 5 лет за каждого referral
(a) | the specific aims and objectives incorporating at least 1-2 milestones as appropriate (no more than 1 page; additional information may be provided in an Appendix) |
|
(b) | A Gantt chart or similar graphical overview of the tasks to be undertaken, their sequence and duration for the entire project including those (marked separately) that will be undertaken in parallel but without AMR Centre funding (if applicable). |
|
| Q15 | PATENT INFORMATION | |
| |||
| (a) | Patent information (continue on another sheet if necessary) | |
| |||
| Application number: | ||
| |||
| Priority date: | ||
| |||
| Inventors: | ||
| |||
| Applicant: | ||
| |||
| Funding source: | ||
| |||
| Title | ||
| |||
Abstract |
| ||
|
| ||
(b) | How do these patent(s) or patent application(s) relate to the proposal? (no more than Ѕ page) |
|
(c) | Describe any new types of intellectual property that can be anticipated (no more than Ѕ page) |
|
Q16 | FREEDOM TO OPERATE AND COMMERCIAL STRATEGY |
(a) | Describe any potential freedom to operate issues that might arise and how this will be tackled. Include the type and date of any searches that have been conducted (no more than Ѕ page) |
|
(b) | Is the proposed project, in whole or in part, subject to any agreements with commercial, academic or other organisations? If yes, give brief details (no more than 200 words). |
|
(c) | Current and downstream regulatory considerations or risks (no more than Ѕ page) |
|
(d) | Describe the competitive landscape, the principle competitors and your competitive advantage (no more than 1 page) |
|
(e) | Describe the R&D strategy and portfolio/pipeline, in the case of companies (no more than Ѕ page) |
|
Curricula Vitae: (Optional)
Q17 | CURRICULUM VITAE OF APPLICANT | |||||||
This section should be completed by the Principal Applicant and all Coapplicants. Please duplicate this section as required. | ||||||||
(a) | Surname: | Forenames: | ||||||
(b) | Title of current post: | |||||||
Date of appointment: (dd/mm/yy) | ||||||||
Expected date of termination: (dd/mm/yy) | ||||||||
(c) | With whom do you have your contract of employment? | |||||||
| ||||||||
(d) | Source of personal salary support: | |||||||
HEFC | NHS | OTHER | Please specify | |||||
Please be specific if salary is funded from more than one source. | ||||||||
(e) | Current salary if salary is being requested as part of this application: | |||||||
If currently funded by a Wellcome Trust grant, please give grant reference number: | ||||||||
(f) | Previous posts held: (list the most recent first) | ||||
| Date from (mm/yyyy) | Date to (mm/yyyy) | Position | Department | Organisation |
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
(g) | Education/training: | |||
| Date (mm/yyyy) | Qualification | Subject | Organisation |
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
(h) | Summary of career to date, including key achievements (no more than 700 words) |
|
(i) | Publications |
Applicants should provide references or examples to 5 key achievements over the past 5 years which may include any of the following: i) Inventions protected by intellectual property rights that have been developed commercially and or adopted; ii) patents that have issued; iii) peer-reviewed publications. Please append to the application in PDF format any references that are particularly relevant. | |
|
(j) | Financial support |
Please list all key forms of financial support in the last 5 years (commercial, research grant, etc.). Please state the name of the funder, title of project or enterprise, amounts awarded and start to end dates of support. For any current grants, indicate the proportion of time spent on each project. | |
|
APPENDIX 1: Tables for presentation of data generated to date on the project.
Table 1. Preferred criteria for a ‘Hit’ stage small-molecule asset
|
Из за большого объема этот материал размещен на нескольких страницах:
1 2 3 4 |


